(Q54705314)

3 June 2018

title

Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma. (English)

1 reference

3 June 2018

1 reference

3

1 reference

3 June 2018

author name string

Yusuke Masuishi

1

1 reference

3 June 2018

Noriaki Arakawa

2

1 reference

3 June 2018

Etsuko Miyagi

4

1 reference

3 June 2018

Fumiki Hirahara

5

1 reference

3 June 2018

Hisashi Hirano

6

1 reference

3 June 2018

language of work or name

English

0 references

publication date

25 March 2011

1 reference

3 June 2018

published in

FEBS Journal

1 reference

3 June 2018

volume

278

1 reference

3 June 2018

issue

9

1 reference

3 June 2018

page(s)

1470-1483

1 reference

3 June 2018

Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Gene expression patterns in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Classifications of ovarian cancer tissues by proteomic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Annexin A4 reduces water and proton permeability of model membranes but does not alter aquaporin 2-mediated water transport in isolated endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Differential lipid specificities of the repeated domains of annexin IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Inositol 3,4,5,6-tetrakisphosphate inhibits the calmodulin-dependent protein kinase II-activated chloride conductance in T84 colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

p53 isoforms can regulate p53 transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Multisite phosphorylation and the integration of stress signals at p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

The ubiquitin ligase COP1 is a critical negative regulator of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

mRNA and 18S-RNA coapplication-reverse transcription for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

Mutagenesis of longer inserts by the ligation of two PCR fragments amplified with a mutation primer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2011.08059.X

10.1111/J.1742-4658.2011.08059.X

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

21348943

1 reference

3 June 2018